Skip to main content

FRONTIER CAPITAL MANAGEMENT CO LLC

Position in BBIO — BridgeBio Pharma, Inc.

CIK 351173 Boston, MA

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$102,265,285
+$31,125,022 QoQ
Shares Held
1,373,057
+43.3% QoQ
Ownership
0.702%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#35
of 472 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 52% Shared 0% None 48%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRONTIER CAPITAL MANAGEMENT CO LLC holds $975,847,387 across 22 Biotechnology names. BBIO ranks #1 (10.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
This page
1,373,057 $102,265,285

All Filings in BBIO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $102,265,285 1,373,057
2026-03-31 $71,140,263 957,989
2025-12-31 $63,190,760 826,131
2025-09-30 $34,261,338 659,633
2025-06-30 $23,134,246 535,763
2025-03-31 $26,594,735 769,301
2024-12-31 $29,521,543 1,075,858
2024-09-30 $12,810,504 503,162
2024-06-30 $3,758,161 148,368
2024-03-31 $13,899,653 449,536